Authors


Jessica Akers

Latest:

How to Improve Life Sciences Promotional Review Committees Using Service Operations Principles

A deep-dive into how pharma companies can apply service operations principles to achieve a greater level of marketing and promotional review committee satisfaction.


Julie Denny

Latest:

Digital-Communication Check: Insights Learned During Lockdown

A look at the results of recent surveys revealing the impact of the COVID-triggered digital switchover on sales rep interactions and medical conferences.


Joerg Tritschler

Latest:

Pharma Forecasting: Key Markets Investors Can’t Ignore

The importance of expanding your pharma sales forecasting horizon beyond the US. Learn how to effectively navigate country-specific regulatory red flags.






John Clarke

Latest:

AI-Enabled Benchmarking: Transforming Performance Measurement for Pharma Brands

Market dynamics boost the need and urgency for more sophisticated benchmarking strategies.


Amish Dhanani

Latest:

To Build AI Maturity, Start With Quick Wins

Companies must determine the right ways to utilize AI.


Eric von Hofe

Latest:

Tuning and Tracking CAR-T Cells for Safer and More Effective Treatment for Solid Tumors

With technological advancements in affinity tuning and real-time tracking of CAR-T cells, the hope is that CAR-T therapy can be effectively applied to treating solid tumors, improve patient outcomes, and avoid the toxicities seen with certain treatments in the clinic.



Mariam Sarwar

Latest:

PREP Act Protections for COVID-19 Vaccine Liability

How PREP Act protections will apply to potential COVID-19 vaccine-related claims.


Alp Perahya

Latest:

Building the Pharma Talent of Tomorrow from Today’s Workforce

Hiring new employees may not be the answer to the war for talent.



Petra Jantzer

Latest:

How Biopharma Can Accelerate Innovation and Sustain Growth

There are clear pathways that biopharma companies can take to sustain growth and remain competitive.



Alan Kalton

Latest:

Fortifying Defenses Pre-Patent Cliff

Integrating artificial intelligence and advanced analytics throughout operations offers pharma companies a pathway to offset impending drug patent expirations.


Darlene Ellenor

Latest:

Embedded and agile–The next phase of the DCT evolution

Ellenor discusses key points from the recent SCOPE presentation.


Michael Shaw

Latest:

How to Wow the Docs

Talk to MDs in their language and build a better brand


Julian Upton

Latest:

A Clear-Headed Approach to Migraine: Vlad Coric, Biohaven

Biohaven CEO Vlad Coric talks to Pharm Exec about NURTEC ODT’s swift and seismic impact on the migraine market.


Charles Goetz

Latest:

How to Wow the Docs

Talk to MDs in their language and build a better brand


Susan Vargas

Latest:

Under Pressure

Promotional spending is down as companies rationalize and optimize budgets. But in contrast to big changes on the sales side, marketers are still trying to make the old model work



Ben Currie, Purohit Navigation

Latest:

Taking It Personally: Building Relationships Online

To increase impact and effectiveness, personalized Web sites should be constructed in different ways to interact with multiple audiences.



Porcher L. Taylor III, University of Richmond

Latest:

Bringing in the Green

Pharma can stand to win hearts, minds, and tax credits by launching an eco bandwagon


Michelle Bertagna Leavy

Latest:

Comparative Effectiveness Research: Coming Soon?

Only time will reveal CER's true definition, and determine the full effects of a CER-based system


John German

Latest:

My DM told me there'd be days like these…

Everyone has bad days, but do you know how to make the best of them?


Sander A. Flaum

Latest:

Time to Step Up

The economy is turning around; leaders need to position their companies now for the market bounce.


Jacky Law

Latest:

Helping Patients Lead the Way in the New NHS

NHS England is currently undergoing profound changes to introduce a new culture where clinicians and patients are the new stars, where competition is mandatory, where everything rests on patient outcomes and where collaboration and innovation are being encouraged at the highest levels of command.